ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Infliximab abrogates adenine-induced chronic kidney disease via modulation of the MAPK/JNK/ASK signaling pathway in rats.

Mahitab M Nageeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.